Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $266,523 - $338,069
-1,453 Reduced 8.16%
16,349 $3.07 Million
Q1 2023

May 10, 2023

BUY
$193.75 - $232.55 $1.92 Million - $2.3 Million
9,888 Added 124.94%
17,802 $4.14 Million
Q4 2022

Feb 09, 2023

SELL
$187.24 - $242.74 $1.74 Million - $2.26 Million
-9,305 Reduced 54.04%
7,914 $1.6 Million
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $2.1 Million - $2.69 Million
-11,849 Reduced 40.76%
17,219 $3.29 Million
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $118,934 - $241,040
655 Added 2.31%
29,068 $5.36 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $388,649 - $542,040
1,279 Added 4.71%
28,413 $9.93 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $318,803 - $387,239
918 Added 3.5%
27,134 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $45,428 - $58,782
-112 Reduced 0.43%
26,216 $10.6 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $665,892 - $859,959
1,786 Added 7.28%
26,328 $12.5 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $1.22 Million - $1.71 Million
-3,387 Reduced 12.13%
24,542 $9.43 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $600,913 - $761,580
2,053 Added 7.93%
27,929 $10.3 Million
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $6.95 Million - $10.4 Million
25,876 New
25,876 $8 Million
Q3 2019

Oct 31, 2019

SELL
$266.84 - $378.23 $4.54 Million - $6.44 Million
-17,020 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$300.59 - $368.15 $213,418 - $261,386
710 Added 4.35%
17,020 $6.27 Million
Q1 2019

Apr 30, 2019

BUY
$272.57 - $321.18 $3.93 Million - $4.63 Million
14,410 Added 758.42%
16,310 $5.07 Million
Q4 2018

Feb 08, 2019

BUY
$272.46 - $366.54 $517,673 - $696,426
1,900 New
1,900 $570,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.